MATRIX Study

MATRIX Study Now Published

MATRIX - A safer way to monitor for subclinical AF

none

top_left

Off

MATRIX Study is the largest clinical evaluation of DX Technology to date.

Can DX technology accurately uncover subclinical AF?

Aren’t most new-onset AF patients already on oral anticoagulation or anti-thrombic therapy?

$What fraction of new-onset AF patients have a high CHA2DS2-VASc score?$

Does AF burden increase over time?

Divider

Study Design & Characteristics

Click to View Press Release

1. Hindricks G, et al. Europace. 2023 Apr 11:euad061. doi: 10.1093/europace/euad061.